a public good project by the
Synthesis
Company
of California

© 2026

Patrizia Chiusolo | doi.page

0 works0 citations0 h-index

Patrizia Chiusolo

Università Cattolica del Sacro Cuore(IT)Agostino Gemelli University Polyclinic(IT)

Publications by Year

Research Areas

Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments

Most-Cited Works

→ The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation(1999)485 cited
→ The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment(2005)248 cited
→ Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells(2005)238 cited
→ Prothrombin G20210A Mutant Genotype Is a Risk Factor for Cerebrovascular Ischemic Disease in Young Patients(1998)230 cited
→ Epidemiology of Factor V Leiden: Clinical Implications(1998)220 cited
→ Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders(2007)202 cited

→ Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies(2009)198 cited

→ Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy(2014)186 cited

→ Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population(2010)181 cited

→ Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial(2015)177 cited